EUVIMEDEUVIMED entdecken
Übersichtsarbeit

AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activity

Rebecca J Leeman-Neill, Govind Bhagat, Uttiya Basu

Advances in Immunology · 2024

DOI: 10.1016/bs.ai.2024.03.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Immunology, 2024. Verfasst von Rebecca J Leeman-Neill und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States; Department of…. Hauptthemen laut MEDLINE: Cytidine Deaminase, Germinal Center, Lymphoma, B-Cell, B-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 224 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activation induced cytidine deaminase (AID) is a key element of the adaptive immune system, required for immunoglobulin isotype switching and affinity maturation of B-cells as they undergo the germinal center (GC) reaction in peripheral lymphoid tissue. The inherent DNA damaging activity of this enzyme can also have off-target effects in B-cells, producing lymphomagenic chromosomal translocations that are characteristic features of various classes of non-Hodgkin B-cell lymphoma (B-NHL), and generating oncogenic mutations, so-called aberrant somatic hypermutation (aSHM). Additionally, AID has been found to affect gene expression through demethylation as well as altered interactions between gene regulatory elements. These changes have been most thoroughly studied in B-NHL arising from GC B-cells. Here, we describe the most common classes of GC-derived B-NHL and explore the consequences of on- and off-target AID activity in B and plasma cell neoplasms. The relationships between AID expression, including effects of infection and other exposures/agents, mutagenic activity and lymphoma biology are also discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytidine DeaminaseGerminal CenterLymphoma, B-CellB-LymphocytesHumansAnimalsSomatic Hypermutation, ImmunoglobulinGene Expression Regulation, NeoplasticImmunoglobulin Class SwitchingAICDA (Activation-Induced Cytidine Deaminase)

Stichwörter der Autor:innen

Aberrant somatic hypermutationActivation-induced cytidine deaminase (AID)B cellsClass switch recombinationNon-Hodgkin B cell lymphomaSomatic hypermutation

Substanzen

Cytidine DeaminaseAICDA (Activation-Induced Cytidine Deaminase)

Autor:innen und Institutionen

  • Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States; Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeo…
  • Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.
  • Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.

Zitieren

APA

Leeman-Neill, R. J., Bhagat, G., & Basu, U. (2024). AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activity. Advances in Immunology. https://doi.org/10.1016/bs.ai.2024.03.005

Vancouver

Leeman-Neill RJ, Bhagat G, Basu U. AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activity. Advances in Immunology. 2024. doi:10.1016/bs.ai.2024.03.005

BibTeX
@article{LeemanNeill2024,
  author = {Leeman-Neill, Rebecca J and Bhagat, Govind and Basu, Uttiya},
  title = {AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activity},
  journal = {Advances in Immunology},
  year = {2024},
  doi = {10.1016/bs.ai.2024.03.005}
}
Kostenlos starten →